BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26348911)

  • 21. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model.
    Kobayashi S; Yano M; Uchinoumi H; Suetomi T; Susa T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Yamamoto T; Matsuzaki M
    Circ J; 2010 Nov; 74(12):2579-84. PubMed ID: 20944434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Cerrone M; Noujaim SF; Tolkacheva EG; Talkachou A; O'Connell R; Berenfeld O; Anumonwo J; Pandit SV; Vikstrom K; Napolitano C; Priori SG; Jalife J
    Circ Res; 2007 Nov; 101(10):1039-48. PubMed ID: 17872467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.
    Pölönen RP; Swan H; Aalto-Setälä K
    Mol Biol Rep; 2020 Feb; 47(2):1067-1077. PubMed ID: 31786768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol tweaks calcium release to ease arrhythmias.
    Knollmann BC
    Nat Med; 2011 Aug; 17(8):923-4. PubMed ID: 21818084
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of carvedilol and perindopril on Ca(2+) pump activity and Ca(2+)-release channel density in myocardial sarcoplasmic reticulum in rats with chronic heart failure following myocardial infarction].
    Geng ZH; Liu CY; Peng YH; Li LG; Zhao XH; Cui B; Yu SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1461-4. PubMed ID: 19620082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic.
    Batiste SM; Blackwell DJ; Kim K; Kryshtal DO; Gomez-Hurtado N; Rebbeck RT; Cornea RL; Johnston JN; Knollmann BC
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):4810-4815. PubMed ID: 30792355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor.
    Ishida R; Zeng X; Kurebayashi N; Murayama T; Mori S; Kagechika H
    Chem Pharm Bull (Tokyo); 2024; 72(4):399-407. PubMed ID: 38644198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2.
    Maizels L; Huber I; Arbel G; Tijsen AJ; Gepstein A; Khoury A; Gepstein L
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ryanodine receptor-targeted anti-arrhythmic therapy.
    Wehrens XH; Lehnart SE; Marks AR
    Ann N Y Acad Sci; 2005 Jun; 1047():366-75. PubMed ID: 16093511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative effect of carvedilol and aerobic exercise training therapies on improving cardiac contractility and remodeling in heart failure mice.
    Vanzelli AS; Medeiros A; Rolim N; Bartholomeu JB; Cunha TF; Bechara LR; Gomes ER; Mattos KC; Sirvente R; Salemi VM; Mady C; Negrao CE; Guatimosim S; Brum PC
    PLoS One; 2013; 8(5):e62452. PubMed ID: 23658728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of Skin Carcinogenesis by the Non-β-blocking R-carvedilol Enantiomer.
    Liang S; Shamim MA; Shahid A; Chen M; Cleveland KH; Parsa C; Orlando R; Andresen BT; Huang Y
    Cancer Prev Res (Phila); 2021 May; 14(5):527-540. PubMed ID: 33648941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characteristics of the stereoisomers of carvedilol.
    Bartsch W; Sponer G; Strein K; Müller-Beckmann B; Kling L; Böhm E; Martin U; Borbe HO
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S104-7. PubMed ID: 1974497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
    Paavola J; Viitasalo M; Laitinen-Forsblom PJ; Pasternack M; Swan H; Tikkanen I; Toivonen L; Kontula K; Laine M
    Eur Heart J; 2007 May; 28(9):1135-42. PubMed ID: 17347175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity.
    Uehara A; Murayama T; Yasukochi M; Fill M; Horie M; Okamoto T; Matsuura Y; Uehara K; Fujimoto T; Sakurai T; Kurebayashi N
    J Gen Physiol; 2017 Feb; 149(2):199-218. PubMed ID: 28082361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol restore cardiac calcium release channel structure and function in heart failure.
    Xue SR; Xue Y; Xue R
    Int J Cardiol; 2007 Mar; 116(2):231-5. PubMed ID: 16824631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
    Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
    Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternans.
    Zhong X; Vallmitjana A; Sun B; Xiao Z; Guo W; Wei J; Ni M; Chen Y; O'Brien ER; Gillis AM; Hoshijima M; Takeshima H; Hove-Madsen L; Benitez R; Belke D; Wayne Chen SR
    Biochem J; 2018 Jan; 475(1):169-183. PubMed ID: 29170159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.
    Jiang D; Xiao B; Zhang L; Chen SR
    Circ Res; 2002 Aug; 91(3):218-25. PubMed ID: 12169647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z; Shioji K; Kihara Y; Takenaka H; Onozawa Y; Kishimoto C
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations.
    Maruyama M; Xiao J; Zhou Q; Vembaiyan K; Chua SK; Rubart-von der Lohe M; Lin SF; Back TG; Chen SR; Chen PS
    Heart Rhythm; 2013 Jan; 10(1):101-7. PubMed ID: 22982970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.